Inactive Instrument

POZEN Inc. Stock

Equities

US73941U1025

Pharmaceuticals

End-of-day quote Nasdaq Other stock markets
- ^USD	-

on all our subscriptions*

Exceptional extension!

Take advantage of the offer

* See conditions on site

Press releases POZEN Inc.

POZEN : Announces Stockholder Approval of its Transaction with Tribute Pharmaceuticals Canada Inc.	16-02-02	PR
POZEN : And Tribute Announce Plan To Proceed With Merger To Form Aralez Pharmaceuticals	15-12-07	PR
POZEN : and Tribute Announce Plan to Proceed With Merger to Form Aralez Pharmaceuticals	15-12-07	MW
POZEN : Reports Third Quarter 2015 Results	15-11-09	BU
POZEN : and Tribute Announce Effectiveness of Registration Statement on Form S-4	15-11-06	BU

More press releases

News in other languages on POZEN Inc.

Sanofi : Pozen met fin à son accord de commercialisation sur 2 médicaments en développement	14-12-01
SANOFI : obtient les droits de commercialisation de médicaments développés par Pozen	13-09-05

Managers and Directors - POZEN Inc.

Managers	Title	Age	Since
John E. Barnhardt ADM	Chief Administrative Officer	74	-

Company Profile

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+34.35%	705B
NOVO NORDISK A/S	+31.07%	583B
JOHNSON & JOHNSON	-3.49%	364B
MERCK & CO., INC.	+20.15%	332B
ABBVIE INC.	+6.19%	291B
ASTRAZENECA PLC	+15.13%	238B
ROCHE HOLDING AG	-3.44%	210B
NOVARTIS AG	+10.09%	209B
AMGEN INC.	+9.21%	169B

Other Pharmaceuticals

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW